HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > RNCOS

Print e mail rss del Y! myWeb Tweet
 

Generics to Dominate US Prescription Drugs Market

Generic drugs market in the US is estimated to grow at a CAGR of around 9% during 2010-2012, says a new research by RNCOS.

 



(EMAILWIRE.COM, April 06, 2010 ) New Delhi, India - The US generics market is the biggest in the world, comprising more than half of the share of the global generics market. The huge potential of this market can be interpreted from its vast pharmaceutical market, which is again the largest in the world. It’s expected that a huge proportion of branded drugs in this market will lose patent protection in coming three years, and thus will open doors for generic substitution. According to our new research on the sector called “Booming US Generic Drug Market”, the generic drugs market in the US is anticipated to grow at a CAGR of around 9% during 2010-2012.

We have identified various decisive factors molding the US generic drugs market towards an exponential growth track. As discussed in the report, generics had an estimated share of around 78% in the US pharmaceuticals market and growth of generics has outpaced the growth of overall pharmaceutical market. The report also discusses the potential of generic drugs in various therapeutics segments of the pharmaceutical industry, which will give a clear idea about the type of products available in the market.

We believe that regulatory environment plays a critical role in the development of generic drugs industry, and our report provides a complete overview of the country’s regulatory environment. Besides the report also discusses several industry bottlenecks that are blocking the growth of generics industry in the country.

“Booming US Generic Drug Market” provides an extensive research and conceptual analysis of the generic drugs market in the US. It covers various growth-supporting factors like macroeconomic environment, healthcare reform plans and its impact and other growth supporting factors. The report thoroughly examines the current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecast in this research has been made considering the possible post-recession impact on the industry.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM589.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.


###
Press release service and press release distribution by EmailWire.Com - http://www.emailwire.com/press_release_distribution_lists.php

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012